BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hussein YM, Morad FE, Gameel MA, Emam WA, El Sawy WH, El Tarhouny SA, Bayomy ES, Raafat N. MAGE-4 gene m-RNA and TGF in blood as potential biochemical markers for HCC in HCV-infected patients.Med Oncol. 2012;29:3055-3062. [PMID: 22653756 DOI: 10.1007/s12032-012-0257-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
Number Citing Articles
1 Banaudha KK, Verma M. Epigenetic biomarkers in liver cancer. Methods Mol Biol 2015;1238:65-76. [PMID: 25421655 DOI: 10.1007/978-1-4939-1804-1_4] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
2 Mattos ÂZ, Debes JD, Boonstra A, Vogel A, Mattos AA. Immune aspects of hepatocellular carcinoma: From immune markers for early detection to immunotherapy. World J Gastrointest Oncol 2021; 13(9): 1132-1143 [PMID: 34616518 DOI: 10.4251/wjgo.v13.i9.1132] [Reference Citation Analysis]
3 Hussein YM, Alhazmi A, Alzahrani S, El-Askary A, Alghamdy A, Bayomy E, Selim A, Alghamdy M. Osteopontin as a marker for response to pegylated interferon Alpha-2b treatment in Chronic HCV Saudi patients. Afr Health Sci 2017;17:366-72. [PMID: 29062331 DOI: 10.4314/ahs.v17i2.10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]